Griffith; Hugh
Patent Applications and Registrations
Patent applications and USPTO patent grants for Griffith; Hugh.The latest application filed is for "2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds".
- Griffith; Hugh - Edinburgh GB
- Griffith; Hugh - Camberley GB
- Griffith; Hugh - Bassett House GB
- Griffith; Hugh - Boise ID
| Patent | Date |
|---|---|
| 2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds App 20220306675 - Griffith; Hugh ; et al. | 2022-09-29 |
| Synthesis of phosphate derivatives Grant 11,414,452 - Griffith , et al. August 16, 2 | 2022-08-16 |
| Cancer treatments Grant 11,400,107 - Griffith , et al. August 2, 2 | 2022-08-02 |
| Crystalline form of gemcitabine Grant 11,377,467 - Griffith July 5, 2 | 2022-07-05 |
| 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds Grant 11,352,387 - Griffith , et al. June 7, 2 | 2022-06-07 |
| Formulation Comprising A Gemcitabine-prodrug App 20220031727 - Griffith; Hugh ; et al. | 2022-02-03 |
| Formulations Of Phosphoramidate Derivatives Of Nucleoside Drugs App 20220031728 - Kennovin; Gordon ; et al. | 2022-02-03 |
| Salt Of Triphosphate Phosphoramidates Of Nucleotides As Anticancer Compounds App 20220024963 - Griffith; Hugh ; et al. | 2022-01-27 |
| Crystalline Form Of Gemcitabine App 20210188893 - Griffith; Hugh | 2021-06-24 |
| Formulation comprising a gemcitabine-prodrug Grant 11,040,051 - Griffith , et al. June 22, 2 | 2021-06-22 |
| Salts Of Diphosphate Phosphoramidate Of Nucleosides As Anticancer Compounds App 20210171566 - Griffith; Hugh ; et al. | 2021-06-10 |
| Phosphoramidate Nucleoside Derivatives As Anticancer Agents App 20210130387 - Griffith; Hugh ; et al. | 2021-05-06 |
| Cancer Treatments Based On Gemcitabine Prodrugs App 20210100825 - Griffith; Hugh ; et al. | 2021-04-08 |
| Phosphoramidate nucleoside derivatives as anticancer agents Grant 10,906,929 - Griffith , et al. February 2, 2 | 2021-02-02 |
| Formulation Comprising A Gemcitabine-prodrug App 20200397810 - Griffith; Hugh ; et al. | 2020-12-24 |
| Treatment Regimens App 20200345755 - Griffith; Hugh | 2020-11-05 |
| Formulation comprising a gemcitabine-prodrug Grant 10,786,523 - Griffith , et al. September 29, 2 | 2020-09-29 |
| Combination Therapy For Cancer App 20200268783 - Griffith; Hugh | 2020-08-27 |
| Gemcitabine Prodrugs App 20200262861 - Griffith; Hugh ; et al. | 2020-08-20 |
| Combination Therapy App 20200197430 - Griffith; Hugh | 2020-06-25 |
| 2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds App 20200181189 - Griffith; Hugh ; et al. | 2020-06-11 |
| Synthesis Of Phosphate Derivatives App 20200181186 - Griffith; Hugh ; et al. | 2020-06-11 |
| Methods of separating gemcitabine-phosphate diastereoisomers Grant 10,669,300 - Griffith | 2020-06-02 |
| Combination therapy for cancer Grant 10,660,912 - Griffith | 2020-05-26 |
| Gemcitabine prodrugs Grant 10,662,213 - Griffith , et al. | 2020-05-26 |
| 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti- cancer compounds Grant 10,570,168 - Griffith , et al. Feb | 2020-02-25 |
| Combination Therapy App 20190381084 - Griffith; Hugh | 2019-12-19 |
| Cancer Treatments App 20190374564 - Griffith; Hugh ; et al. | 2019-12-12 |
| Phosphoramidate Nucleoside Derivatives As Anticancer Agents App 20190375779 - Griffith; Hugh | 2019-12-12 |
| Adenosine Derivatives For Use In The Treatment Of Cancer App 20190375778 - Griffith; Hugh ; et al. | 2019-12-12 |
| Combination Therapy App 20190022117 - Griffith; Hugh | 2019-01-24 |
| Formulation Comprising A Gemcitabine-prodrug App 20190022118 - Griffith; Hugh ; et al. | 2019-01-24 |
| Formulations Of Phosphoramidate Derivatives Of Nucleoside Drugs App 20180369266 - Kennovin; Gordon ; et al. | 2018-12-27 |
| Formulation comprising a gemcitabine-prodrug Grant 10,117,888 - Griffith , et al. November 6, 2 | 2018-11-06 |
| Cancer Treatments Based On Gemcitabine Prodrugs App 20180289733 - Griffith; Hugh ; et al. | 2018-10-11 |
| Combination Therapy For Cancer App 20180271889 - Griffith; Hugh | 2018-09-27 |
| 2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds App 20170253629 - Griffith; Hugh ; et al. | 2017-09-07 |
| Methods Of Separating Gemcitabine-phosphate Diastereoisomers App 20170226147 - Griffith; Hugh | 2017-08-10 |
| Gemcitabine Prodrugs App 20170107246 - Griffith; Hugh ; et al. | 2017-04-20 |
| Formulation Comprising A Gemcitabine-prodrug App 20170095498 - Griffith; Hugh ; et al. | 2017-04-06 |
| Timed Reading Experience Electronic Book App 20120154372 - Buck; Brian ; et al. | 2012-06-21 |
| SEC | 0001296964 | Griffith Hugh |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 